abstract |
(57) [Summary]nThe present invention provides a genetically modified gene having a self-reactive receptor, retaining at least one exogenously introduced gene in the genome, and the gene capable of expressing one (poly) peptide. T cells. Furthermore, the present invention relates to a pharmaceutical composition comprising said T cells. |